Pfizer (PFE) Phase 3 study; sigvotatug vedotin did not show a statistically significant improvement in the primary endpoint of overall survival compared to docetaxel

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

Oman's Foreign Minister meets with Iranian Parliamentary Speaker Ghalibaf, with the officials discussing regional stability and Strait of Hormuz

[CALENDAR ADDITION] Fed Chair Warsh is to testify at the House Financial Services Committee on July 14th at 10:00EDT/15:00BST

Pfizer (PFE) Phase 3 study; sigvotatug vedotin did not show a statistically significant improvement in the primary endpoint of overall survival compared to docetaxel

Meta (META) pauses internal AI training programme after sensitive data was accessible across entire company, reports Business Insider

US President Trump on defence contractors, says that stock buybacks are not allowed and they are a fake way to raise the price

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free